Webinar Invitation | The Art of Complex PCI: Global Perspectives on Strategies for Challenging Coronary Lesions
Release time:
2026-09-14
As coronary interventions continue to advance, the treatment of complex lesions increasingly calls for more refined strategies, stronger clinical evidence, and closer exchange across regions.
On September 23, 2026, BrosMed Medical will bring together distinguished interventional cardiologists around the world for “The Art of Complex PCI: Global Perspectives on Strategies for Challenging Coronary Lesions.”
More than an international webinar, this event marks an important step in BrosMed’s continued commitment to building a connected global platform for complex PCI education. Drawing on clinical evidence, procedural experience, and real-world practice, the faculty will exchange perspectives on navigating challenging coronary anatomies and translating evidence into informed procedural decision-making.
The scientific program will explore the application of the BrosMed Complex PCI Toolkit, featuring the RevoEdge™ HP Coronary Cutting Balloon, Eagle™ Guidewire, POT™ PTCA Balloon, Alveo™ HP CTO Balloon, Pronavi™ Microcatheter, and Wedge™ NC Balloon across different stages of complex PCI.
We warmly invite interventional cardiologists and healthcare professionals worldwide to join this important scientific exchange.
Event Details
Date: Wednesday, September 23, 2026
Time: 15:30–17:00 (GMT+8)
Registration: https://global.drvoice.cn/v2/course/4620
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
